Home Galena Biopharma Inc (GALE) Price Target Lowered to $6.00 at Roth Capital
 

Keywords :   


Galena Biopharma Inc (GALE) Price Target Lowered to $6.00 at Roth Capital

2016-01-01 17:14:30| Biotech - Topix.net

The brokerage presently has a "buy" rating on the biotechnology company's stock. Roth Capital's price objective indicates a potential upside of 308.16% from the company's current price.

Tags: price capital target gale

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
More »